Spark 728-3030Recalls & reported problems
Ormco Corporation · Spark Advanced - Dual Arch · Class 2
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00889989083460), received between May 22, 2020 and Feb 18, 2026 — classified as 4 injuries.
The most frequently reported specific device problem is “Patient Device Interaction Problem” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Patient Device Interaction Problem3
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Local Reaction2
- Swelling1
- Tooth Fracture1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryFeb 18, 2026Patient Device Interaction Problem
IT WAS REPORTED A PATIENT BEGAN TREATMENT WITH SPARK ALIGNERS AND, AFTER TWO MONTHS OF USE, DEVELOPED SIGNIFICANT CRACKING OF THE ANTERIOR TEETH. DUE TO THE SEVERITY OF THE FRACTURES, THE AFFECTED TEETH WILL REQUIRE EXTRACTION.
Patient problems: Tooth Fracture
MAUDE report 24381658 ↗InjuryDec 20, 2023Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED A PATIENT HAD A SEVERE ALLERGIC REACTION. PATIENT EXPERIMENTED SEVERE SWELLING OF UPPER AND LOWER LIPS FOUR (4) DAYS AFTER STARTING THE FIRST ALIGNER OF THE INITIAL SET. BASED ON DOCTOR'S PROFESSIONAL OPINION, ALLERGIC REACTION IS CONSIDERED ADVERSE EVENT BECAUSE IF THE PATIENT CONTINUE WITH WEARING THE ALIGNERS THE ALLERGY COULD WORSEN. PATIENT DID NOT SEEK MEDICAL ATTENTION WITH A DOCTOR AND DID NOT GO TO HOSPITAL FOR THESE SYMPTOMS. PATIENT TOOK A HEAVY DOSE OF BENADRYL TO REDUCE THE SWOLLEN OF THE LIPS. DOCTOR REQUESTED THE PATIENT NOT TO WEAR THE ALIGNERS AND THE SYMPTOMS DISAPPEAR. PATIENT IS FULLY RECOVERED BUT CURRENTLY IS NOT WEARING THE ALIGNERS.
Patient problems: Local Reaction
MAUDE report 18368708 ↗InjurySep 29, 2023Patient Device Interaction Problem; Patient Device Interaction Problem
IT WAS REPORTED A PATIENT DEVELOPED A SEVERE MEDICAL COMPLICATION FROM AN ALLERGIC RESPONSE TO THE ALIGNERS. PATIENT FIRST REPORTED SENSATION OF TINGLING AND BITTERNESS TASTE IN HER TONGUE AFTER 2 DAYS OF WEARING ALIGNERS. DOCTOR SUGGESTED HER TO WEAR THE ALIGNERS FOR A FULL WEEK SINCE THERE IS AN ADJUSTMENT PERIOD TO ALIGNERS. AFTER 1 WEEK OF WEARING THEM, PATIENT REPORTED THAT HER SYMPTOMS HAD NOT IMPROVED. BUT WORSENED. PATIENT LOOKED FOR MEDICAL ATTENTION WITH A FAMILIAR MEDICINE DOCTOR FOR THIS REACTION. THE DIAGNOSIS WAS EDEMA OF THE EPIGLOTTIS FROM ALLERGIC REACTION. IT WAS PRESCRIBED ZYRTEC AND THE PATIENT IS FULLY RECOVERED.
Patient problems: Local Reaction
MAUDE report 17844450 ↗InjuryMay 22, 2020Adverse Event Without Identified Device or Use Problem
THE PATIENT HAS AN ANGIOEDEMA DIAGNOSIS AND HAS SWELLING IN HER MOUTH WHEN WEARING THE SPARK ALIGNERS.
Patient problems: Swelling
MAUDE report 10083283 ↗
Other Aligner, Sequential devices
- Byte Day Alignes HBYTETrayStraight Smile LLC · Aligner, Sequential1 recall6,719 reports
- Byte Night Aligners NBYTETrayStraight Smile LLC · Aligner, Sequential1 recall6,053 reports
- sequential aligner 100-0352Access Dental Lab, LLC · Aligner, Sequential322 reports
- Invisalign System - Comprehensive 9000Align Technology, Inc. · Aligner, Sequential239 reports
- SureSmile® 1000Orametrix, Inc. · Aligner, Sequential134 reports
- REFINEMENT CORRECTION KIT 100-0012Access Dental Lab, LLC · Aligner, Sequential120 reports
- Candid Aligner FA-0001Candid Care CO. · Aligner, Sequential54 reports
- 3M™ Clarity™ 359-8363m Unitek Corporation · Aligner, sequential1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.